The average survival in dogs with axial osteosarcomas is 4 - 5 months, and the most common cause of treatment failure is
local tumor recurrence.
In dogs, the size of malignant mammary tumors is an important consideration when determining prognosis, both for
local tumor recurrence and survival time.
Also, no evidence of
local tumor recurrence.
If the mammary tumor is malignant, the surgical site and regional lymph nodes should be checked for
local tumor recurrence and metastasis, respectively, every 3 months for the first 12 months after surgery and then every 6 months thereafter.
The complications that might arise after limb - sparing surgery could be implant failure,
local tumor recurrence, and infection.
When complete removal of the tumor is not possible with the partial ulnectomy, radiation therapy may be beneficial to prevent
local tumor recurrence.
Local tumor recurrence or tumor progression can be delayed by months to years with CFRT, and a local cure may be obtained in many instances.
Not exact matches
A pre-surgery
tumor size of greater than three centimeters was associated with worse LC, but
local recurrence was not significantly affected by the number of brain metastases or the patients» histology or graded prognosis assessments.
Radiosurgery to the surgical bed significantly reduced
local recurrence of the resected
tumor.
Nine additional patients had
recurrence within the involved lobe (range, 0.1 to 5.9 years after SBRT), resulting in a five - year primary
tumor and involved lobe (
local) failure rate of 20 percent.
Abrogation of
local cancer
recurrence after radiofrequency ablation by dendritic cell - based hyperthermic
tumor vaccine.
Grade 1
tumors had the lowest post-surgery peak for
local recurrence, while grades 2 and 3 showed similar rates.
There was also variation based on histology, with the highest rate of
local recurrence at about a year after surgery seen in malignant peripheral nerve sheath
tumors (MPNST), followed by myxofibrosarcoma; both those types saw persistently elevated rates compared to other subtypes out beyond 5 years.
Consequently, most patients with advanced disease have died from a
local recurrence of their
tumor, even after aggressive treatment.
The veterinary pathologist usually adds a prognosis that describes the probability of
local recurrence or metastasis (distant spread), and will usually assess the completeness of excision of the
tumor.
Obviously, the recommendation to inject vaccines at distal limb sites is intended to facilitate complete removal of the
tumor and minimize the risk of
local recurrence, following amputation of the affected limb.
Local recurrence of the
tumor or spread of the cancer that was not detected at the time of surgery